tiprankstipranks
Trending News
More News >
Xbrane Biopharma AB (DE:7XB)
BERLIN:7XB
Germany Market
Advertisement

Xbrane Biopharma AB (7XB) Technical Analysis

Compare
4 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Xbrane Biopharma AB’s (7XB) Moving Averages Convergence Divergence (MACD) indicator is -0.51, suggesting Xbrane Biopharma AB is a Buy.
Xbrane Biopharma AB’s (7XB) 20-Day exponential moving average is 2.61, while Xbrane Biopharma AB’s (7XB) share price is €1.26, making it a Sell.
Xbrane Biopharma AB’s (7XB) 50-Day exponential moving average is 3.03, while Xbrane Biopharma AB’s (7XB) share price is €1.26, making it a Sell.

Xbrane Biopharma AB (7XB) Pivot Points

Oct 26, 2025, 07:08 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.24
1.24
1.24
1.24
1.24
1.24
1.24
Fibonacci
1.24
1.24
1.24
1.24
1.24
1.24
1.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xbrane Biopharma AB (7XB) Moving Averages

Oct 26, 2025, 07:08 AM
Period
Simple
Exponential
MA5
1.59Sell
1.62Sell
MA10
2.40Sell
2.12Sell
MA20
2.89Sell
2.61Sell
MA50
3.26Sell
3.03Sell
MA100
3.22Sell
3.09Sell
MA200
2.82Sell
2.84Sell
Xbrane Biopharma AB’s (7XB) 10-Day exponential moving average is 2.12, while Xbrane Biopharma AB’s (7XB) share price is €1.26, making it a Sell.
Xbrane Biopharma AB’s (7XB) 100-Day exponential moving average is 3.09, while Xbrane Biopharma AB’s (7XB) share price is €1.26, making it a Sell.
Xbrane Biopharma AB’s (7XB) stock price is €1.26 and Xbrane Biopharma AB’s (7XB) 50-day simple moving average is 3.26, creating a Sell signal.
Xbrane Biopharma AB’s (7XB) stock price is €1.26 and Xbrane Biopharma AB’s (7XB) 100-day simple moving average is 3.22, creating a Sell signal.
Xbrane Biopharma AB’s (7XB) stock price is €1.26 and Xbrane Biopharma AB’s (7XB) 200-day simple moving average is 2.82, creating a Sell signal.

Xbrane Biopharma AB (7XB) Technical Indicators

Oct 26, 2025, 07:08 AM
Name
Value
Implied Action
RSI (14)
23.60
Buy
STOCH (9,6)
0.93
Buy
STOCHRSI (14)
0.90
Buy
MACD (12,26)
-0.51
Buy
ADX (14)
41.21
Neutral
Williams %R
-97.33
Buy
CCI (14)
-164.64
Buy
ATR (14)
0.46
-
Ultimate Oscillator
33.04
Neutral
ROC
-57.24
Sell
Xbrane Biopharma AB’s (7XB) Relative Strength Index (RSI) is 23.60, creating a Buy signal.
Xbrane Biopharma AB’s (7XB) Trend Strength Indicator (ADX) is 41.21, creating a Neutral signal.
Xbrane Biopharma AB’s (7XB) Commodity Channel Index (CCI) is -164.64, creating a Buy signal.
Xbrane Biopharma AB’s (7XB) Price Rate of Change (ROC) is -57.24, creating a Sell signal.

FAQ

Is 7XB a Buy, Hold, or Sell?
Based on 7XB’s technical indicators, 7XB is a Sell.
    What is 7XB’s RSI (14)?
    7XB’s RSI (14) is 23.60, which suggests 7XB is a Buy.
      What is 7XB’s MACD?
      7XB’s MACD is -0.51, which suggests 7XB is a Buy.
        What is 7XB’s 5-day moving average?
        7XB’s 5-day moving average is 1.59, which suggests 7XB is a Sell.
          What is 7XB’s 20-day moving average?
          7XB 20-day moving average is 2.89, which suggests 7XB is a Sell.
            What is 7XB’s 50-day moving average?
            7XB’s 50-day moving average is 3.26, which suggests 7XB is a Sell.
              What is 7XB’s 200-day moving average?
              7XB’s 200-day moving average is 2.82, which suggests 7XB is a Sell.
                What is 7XB’s Williams % R (14)?
                7XB’s Williams % R (14) is -97.33, which suggests 7XB is a Buy.
                  What is 7XB’s CCI (14)?
                  7XB’s CCI (14) is -164.64, which suggests 7XB is a Buy.
                    What is the share price of Xbrane Biopharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis